The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS): Framework and methodology

Patients with early‐onset Alzheimer's disease (EOAD) are commonly excluded from large‐scale observational and therapeutic studies due to their young age, atypical presentation, or absence of pathogenic mutations. The goals of the Longitudinal EOAD Study (LEADS) are to (1) define the clinical, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Apostolova, Liana G., Aisen, Paul, Eloyan, Ani, Fagan, Anne, Fargo, Keith N., Foroud, Tatiana, Gatsonis, Constantine, Grinberg, Lea T., Jack, Clifford R., Kramer, Joel, Koeppe, Robert, Kukull, Walter A., Murray, Melissa E., Nudelman, Kelly, Rumbaugh, Malia, Toga, Arthur, Vemuri, Prashanthi, Trullinger, Amy, Iaccarino, Leonardo, Day, Gregory S., Graff‐Radford, Neill R., Honig, Lawrence S., Jones, David T., Masdeu, Joseph, Mendez, Mario, Musiek, Erik, Onyike, Chiadi U., Rogalski, Emily, Salloway, Steve, Wolk, David A., Wingo, Thomas S., Carrillo, Maria C., Dickerson, Bradford C., Rabinovici, Gil D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939858/
https://www.ncbi.nlm.nih.gov/pubmed/34018654
http://dx.doi.org/10.1002/alz.12350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939858/
https://www.ncbi.nlm.nih.gov/pubmed/34018654
http://dx.doi.org/10.1002/alz.12350

Ejemplares similares